tiprankstipranks

Thomas Schall Insider Profile

11 Followers
Thomas Schall, President & CEO, Director at ChemoCentryx, holds 2.90K shares in Immuneering (Ticker: IMRX), holds 0.00 shares in ChemoCentryx (Ticker: CCXI). Most recently, Thomas Schall Bought ― shares of Immuneering on Mar 25, 2024 for an estimated value of 7.37K.
tipranks
Thomas Schall

Thomas Schall
ChemoCentryx (CCXI)
President & CEO, Director

Ranked #52,000 out of 98,501 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

-2.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$5K
100.00%
A breakdown of Thomas Schall's holdings

Insider Roles

Immuneering
(IMRX)
Director
Roles that Thomas Schall holds in companies

Most Profitable Insider Trade

Stock:
ChemoCentryx
(CCXI)
Rating:Informative Sell
Date:May 23, 2018 - May 23, 2019
Return:+11.30%
The most profitable trade made by Thomas Schall

Thomas Schall's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
CCXI
ChemoCentryx
Oct 24, 2022
Uninformative Sell
$0.00
Immuneering
Mar 25, 2024
Director
Informative Buy
7.37K
$5.39K
List of latest transactions for each holding click on a transaction to see Thomas Schall's performance on stock

Thomas Schall insider profile FAQ

What is the percentage of profitable transactions made by Thomas Schall?
The percentage of profitable transactions made by Thomas Schall is 50%.
    What is the average return per transaction made by Thomas Schall?
    The average return per transaction made by Thomas Schall is -2.80%.
      What stocks does Thomas Schall hold?
      Thomas Schall holds: CCXI, IMRX stocks.
        What was Thomas Schall’s latest transaction?
        Thomas Schall latest transaction was an Informative Buy of $7.37K.
          What was Thomas Schall's most profitable transaction?
          Thomas Schall’s most profitable transaction was an Informative Sell of CCXI stock on May 23, 2018. The return on the trade was 11.30%.
            What is Thomas Schall's role in ChemoCentryx?
            Thomas Schall's role in ChemoCentryx is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.